{"id": "oMCBfAgAAAAJ", "citedby": 980, "citedby5y": 597, "hindex": 14, "hindex5y": 12, "i10index": 18, "i10index5y": 15, "coauthors": [{"id": "pkcyxe8AAAAJ", "name": "RONALD S. GO MD", "affiliation": "Mayo Clinic"}, {"id": "d27Ji6kAAAAJ", "name": "Reka Albert", "affiliation": "Distinguished Professor, Penn State"}, {"id": "60ZCtZMAAAAJ", "name": "Jianhua Yu", "affiliation": "The City of Hope National Medical Center and Beckman Research Institute"}, {"id": "RxlpA7YAAAAJ", "name": "shengjun tan", "affiliation": "Assistant Investigator of Institute of Zoology, Chinese Academy of Sciences"}, {"id": "5VMV3zcAAAAJ", "name": "Gaurav Goyal", "affiliation": "monsanto"}], "name": "Mithun V. Shah", "affiliation": "Mayo Clinic", "interests": ["Stem cell transplant", "Immunology", "Cancer biology", "Immunotherapy", "Cell theapy"], "cites_per_year": {"2008": 5, "2009": 25, "2010": 25, "2011": 66, "2012": 70, "2013": 75, "2014": 76, "2015": 64, "2016": 72, "2017": 72, "2018": 111, "2019": 173, "2020": 98}, "publications": [{"bib": {"title": "Network model of survival signaling in large granular lymphocyte leukemia", "year": "2008"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:u5HHmVD_uO8C", "citedby": "316"}, {"bib": {"title": "Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes", "year": "2008"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:u-x6o8ySG0sC", "citedby": "117"}, {"bib": {"title": "NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human", "year": "2011"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:2osOgNQ5qMEC", "citedby": "75"}, {"bib": {"title": "Change in Pattern of HER2 Fluorescent in Situ Hybridization (FISH) Results in Breast Cancers Submitted for FISH Testing: Experience of a Reference Laboratory \u2026", "year": "2016"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:isC4tDSrTZIC", "citedby": "55"}, {"bib": {"title": "The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders", "year": "2010"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:d1gkVwhDpl0C", "citedby": "52"}, {"bib": {"title": "Therapeutic efficacy of FTY720 in a rat model of NK-cell leukemia", "year": "2011"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:UeHWp8X0CEIC", "citedby": "47"}, {"bib": {"title": "Acid ceramidase is upregulated in AML and represents a novel therapeutic target", "year": "2016"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:hMod-77fHWUC", "citedby": "34"}, {"bib": {"title": "Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia", "year": "2015"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:dhFuZR0502QC", "citedby": "30"}, {"bib": {"title": "\u201cPATIENT DEMAND\u201d POSTOPERATIVE ANALGESIA WITH BUPRENORPHINE: Comparison Between Sublingual and im Administration", "year": "1986"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:1yQoGdGgb4wC", "citedby": "30"}, {"bib": {"title": "Haploidentical transplantation for older patients with acute myeloid leukemia and myelodysplastic syndrome", "year": "2018"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:70eg2SAEIzsC", "citedby": "23"}, {"bib": {"title": "Clinical and radiologic responses to cladribine for the treatment of Erdheim-Chester disease", "year": "2017"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:ns9cj8rnVeAC", "citedby": "20"}, {"bib": {"title": "A population-based study of large granular lymphocyte leukemia", "year": "2016"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:k_IJM867U9cC", "citedby": "20"}, {"bib": {"title": "Never say die: survival signaling in large granular lymphocyte leukemia", "year": "2009"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:9yKSN-GCB0IC", "citedby": "19"}, {"bib": {"title": "Early post-transplant minimal residual disease assessment improves risk stratification in acute myeloid leukemia", "year": "2018"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:O3NaXMp0MMsC", "citedby": "16"}, {"bib": {"title": "Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease", "year": "2020"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:SP6oXDckpogC", "citedby": "10"}, {"bib": {"title": "Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:CHSYGLWDkRkC", "citedby": "10"}, {"bib": {"title": "Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor \u2026", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:f2IySw72cVMC", "citedby": "10"}, {"bib": {"title": "Efficacy of biological agents in the treatment of Erdheim-Chester disease.", "year": "2018"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:2P1L_qKh6hAC", "citedby": "10"}, {"bib": {"title": "Adult disseminated Langerhans cell histiocytosis: incidence, racial disparities and long\u2010term outcomes", "year": "2018"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:RYcK_YlVTxYC", "citedby": "8"}, {"bib": {"title": "Changing pattern for HER2 positivity due to updated ASCO/CAP guidelines for HER2 testing and its impact.", "year": "2015"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:QIV2ME_5wuYC", "citedby": "7"}, {"bib": {"title": "Impact of genetic targets on cancer therapy", "year": "2013"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:Wp0gIr-vW9MC", "citedby": "7"}, {"bib": {"title": "Impact of genetic targets on cancer therapy in acute myelogenous leukemia", "year": "2013"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:Tyk-4Ss8FVUC", "citedby": "7"}, {"bib": {"title": "The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease \u2026", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:bnK-pcrLprsC", "citedby": "6"}, {"bib": {"title": "Arterial involvement in Erdheim\u2013Chester disease: A retrospective cohort study", "year": "2018"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:bFI3QPDXJZMC", "citedby": "6"}, {"bib": {"title": "Adult Langerhans cell histiocytosis: A contemporary single-institution series of 186 patients.", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:p2g8aNsByqUC", "citedby": "5"}, {"bib": {"title": "Elderly acute lymphoblastic leukemia: a Mayo Clinic study of 124 patients", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:pyW8ca7W8N0C", "citedby": "5"}, {"bib": {"title": "Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics", "year": "2012"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:4DMP91E08xMC", "citedby": "4"}, {"bib": {"title": "Sensitive PCR\u2010based monitoring and early detection of relapsed JAK2 V617F myelofibrosis following transplantation", "year": "2018"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:HoB7MX3m0LUC", "citedby": "3"}, {"bib": {"title": "Primary plasma cell leukemia: stem cell transplant in an era of novel induction drugs", "year": "2018"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:zA6iFVUQeVQC", "citedby": "3"}, {"bib": {"title": "Clinical and radiological responses to oral methotrexate alone or in combination with other agents in Erdheim-Chester disease", "year": "2017"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:pqnbT2bcN3wC", "citedby": "3"}, {"bib": {"title": "Clinical presentation, diagnosis, treatment, and outcome of patients with Erdheim-Chester disease: the Mayo Clinic experience", "year": "2014"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:mVmsd5A6BfQC", "citedby": "3"}, {"bib": {"title": "Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:_xSYboBqXhAC", "citedby": "2"}, {"bib": {"title": "OR32-1 Endocrine Manifestations of Erdheim-Chester Disease: The Mayo Clinic Experience", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:uWQEDVKXjbEC", "citedby": "2"}, {"bib": {"title": "Analysis of serum ferritin levels as a diagnostic criteria for hemophagocytic lymphohistiocytosis (HLH) in hospitalized adult patients", "year": "2015"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:RHpTSmoSYBkC", "citedby": "2"}, {"bib": {"title": "Erdheim-Chester Disease", "year": "2015"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:ZeXyd9-uunAC", "citedby": "2"}, {"bib": {"title": "I SURREY", "year": "2009"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:XiVPGOgt02cC", "citedby": "2"}, {"bib": {"title": "Bone marrow findings in Erdheim-Chester disease: increased prevalence of chronic myeloid neoplasms", "year": "2020"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:t6usbXjVLHcC", "citedby": "1"}, {"bib": {"title": "Single-Agent Cladribine As an Effective Therapy for Adults with Langerhans Cell Histiocytosis", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:WA5NYHcadZ8C", "citedby": "1"}, {"bib": {"title": "The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS.", "year": "2018"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:D03iK_w7-QYC", "citedby": "1"}, {"bib": {"title": "HLA-mismatched bone marrow transplantation in severe aplastic anemia", "year": "2017"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:lSLTfruPkqcC", "citedby": "1"}, {"bib": {"title": "Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia Patients", "year": "2017"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:KxtntwgDAa4C", "citedby": "1"}, {"bib": {"title": "Association of hemophagocytic lymphohistiocytosis (HLH) with poor outcomes in adults with NK-and T-cell lymphoma (NKTCL).", "year": "2015"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:GnPB-g6toBAC", "citedby": "1"}, {"bib": {"title": "EBV-positive peripheral T-cell lymphoma with extensive hemophagocytosis.", "year": "2014"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:9ZlFYXVOiuMC", "citedby": "1"}, {"bib": {"title": "Large Granular Lymphocyte Leukemia\u2013From Molecular Pathogenesis to Targeted Therapy", "year": "2012"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:zYLM7Y9cAGgC", "citedby": "1"}, {"bib": {"title": "Epigenetic modulation of Alemtuzumab mediated antileukemia effects and resistance in T-cell prolymphocytic leukemia", "year": "2011"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:YsMSGLbcyi4C", "citedby": "1"}, {"bib": {"title": "The Differential Diagnosis of Basophilia in Patients Undergoing BCR-ABL Testing.", "year": "2020"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:UHK10RUVsp4C", "citedby": "0"}, {"bib": {"title": "Baseline immune dysregulation in autologous stem cell transplant recipients is associated with a \u2018graft versus host\u2019-like syndrome and poor outcomes", "year": "2020"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:PR6Y55bgFSsC", "citedby": "0"}, {"bib": {"title": "Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis", "year": "2020"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:hkOj_22Ku90C", "citedby": "0"}, {"bib": {"title": "Low-Dose Total Body Irradiation (TBI) Use As Part of Pre-Transplant Conditioning Regimen Is Associated with Worse Outcomes in Patients with Severe Aplastic Anemia (SAA) Treated \u2026", "year": "2020"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:ZuybSZzF8UAC", "citedby": "0"}, {"bib": {"title": "Impact of marrow blasts percentage on high-grade myelodysplastic syndrome assessed using revised international prognostic scoring system", "year": "2020"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:VL0QpB8kHFEC", "citedby": "0"}, {"bib": {"title": "Use of Sublingual Tacrolimus in Adults Undergoing Hematopoietic Cell Transplant: A Pilot Study", "year": "2020"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:ye4kPcJQO24C", "citedby": "0"}, {"bib": {"title": "IMPACT OF A MULTI-DISCIPLINARY TUMOR BOARD ON THE CARE OF PATIENTS WITH HISTIOCYTIC DISORDERS: THE MAYO CLINIC HISTIOCYTOSIS WORKING GROUP (HWG) EXPERIENCE", "year": "2020"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:5awf1xo2G04C", "citedby": "0"}, {"bib": {"title": "Clinical Utility of Fluorescence In Situ Hybridization-based Diagnosis of BCR-ABL1 like (Philadelphia Chromosome like) B-Acute Lymphoblastic Leukemia.", "year": "2020"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:WqliGbK-hY8C", "citedby": "0"}, {"bib": {"title": "Indoleamine 2, 3-dioxygenase-1 expressing aggregate bone marrow dendritic cell populations are associated with systemic T cell compartment changes in chronic myelomonocytic \u2026", "year": "2020"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:JQOojiI6XY0C", "citedby": "0"}, {"bib": {"title": "Extranodal Rosai-Dorfman Disease Presenting as a Pericardial Mass and Constrictive Pericarditis", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:eq2jaN3J8jMC", "citedby": "0"}, {"bib": {"title": "Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Flurabine Improves Transplant Outcomes in Older MDS Patients", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:SdhP9T11ey4C", "citedby": "0"}, {"bib": {"title": "Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for Lymphoma", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:9vf0nzSNQJEC", "citedby": "0"}, {"bib": {"title": "Molecular Alterations in Adult Histiocytic Neoplasms", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:dTyEYWd-f8wC", "citedby": "0"}, {"bib": {"title": "Desideromastica: Tactile Chew Cravings in Iron Deficiency Anemia", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:JoZmwDi-zQgC", "citedby": "0"}, {"bib": {"title": "Correlation of Flow Cytometric Aberrations with Cytogenetic, Molecular Genetic, and Morphology in Patients with Unexplained Cytopenias", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:PELIpwtuRlgC", "citedby": "0"}, {"bib": {"title": "Low-Dose BRAF-Inhibitors in the Treatment of Histiocytic Disorders with the BRAF-V600E Mutation", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:_B80troHkn4C", "citedby": "0"}, {"bib": {"title": "Clinical Features and Outcomes of Unifocal Adult Langerhans Cell Histiocytosis", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:tkaPQYYpVKoC", "citedby": "0"}, {"bib": {"title": "Discrepancy of Blast Percentage between the Bone Marrow Aspirate and Flow Cytometry and Its Impact on Survival Outcomes in Patients with Myelodysplastic Syndromes Excess Blast \u2026", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:Y5dfb0dijaUC", "citedby": "0"}, {"bib": {"title": "Survival Outcomes Following Allogeneic Stem Cell Transplantation for Inherited Bone Marrow Failure and Myeloid Germline Predisposition Syndromes", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:eMMeJKvmdy0C", "citedby": "0"}, {"bib": {"title": "Acute Myeloid Leukemia with High Risk Features: Routine Central Nervous System Evaluation May be Beneficial", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:AXPGKjj_ei8C", "citedby": "0"}, {"bib": {"title": "Characteristics and Outcomes of Therapy Related Myeloid Neoplasms in Patients with Multiple Myeloma Following Autologous Stem Cell Transplantation", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:Mojj43d5GZwC", "citedby": "0"}, {"bib": {"title": "PD-1/PD-L1 expression in extramedullary lesions of acute myeloid leukemia", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:olpn-zPbct0C", "citedby": "0"}, {"bib": {"title": "Discrepancy of blast percentage between the bone marrow aspirate and biopsy and its impact on survival outcomes in patients with myelodysplastic syndromes excess blast (MDS-EB).", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:XiSMed-E-HIC", "citedby": "0"}, {"bib": {"title": "Clinical features, molecular aberrations, treatments, and outcomes in histiocytic sarcoma.", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:u9iWguZQMMsC", "citedby": "0"}, {"bib": {"title": "Pyridoxine impact on patients with myelodysplastic syndromes with ring sideroblasts: Single institution retrospective study.", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:OU6Ihb5iCvQC", "citedby": "0"}, {"bib": {"title": "QIM19-136: Developing an Ideal CAR-T Cell Therapy Patient Experience Through Human-Centered Design and Innovation", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:UxriW0iASnsC", "citedby": "0"}, {"bib": {"title": "Impact of Allogeneic Stem Cell Transplant on Outcomes of Patients with Acute Myeloid Leukemia Based on NPM1 and FLT3 Mutational Status", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:nb7KW1ujOQ8C", "citedby": "0"}, {"bib": {"title": "Long-Term Outcomes after Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:P5F9QuxV20EC", "citedby": "0"}, {"bib": {"title": "Relapse Rates in Patients Receiving Azithromycin for the Treatment of Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplant", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:1sJd4Hv_s6UC", "citedby": "0"}, {"bib": {"title": "Cutaneous blastic plasmacytoid dendritic cell neoplasm arising in the context of TET2 and ZRSR2 mutated clonal cytopenias of unknown significance, secondary to somatic copy \u2026", "year": "2019"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:HE397vMXCloC", "citedby": "0"}, {"bib": {"title": "The Clinical Utility of Pharmacogenomics Testing in Assessing Tyrosine Kinase Inhibitor Therapy, Intolerance and Responses in Patients with Chronic Myelogenous Leukemia", "year": "2018"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:abG-DnoFyZgC", "citedby": "0"}, {"bib": {"title": "Tumor Mutational Burden and Other Immunotherapy Markers in Histiocytic Neoplasms Using Next Generation Sequencing", "year": "2018"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:b0M2c_1WBrUC", "citedby": "0"}, {"bib": {"title": "Marrow Blast Percentage Impact on High-Grade Myelodysplastic Syndrome By the Revised International Prognostic Scoring System", "year": "2018"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:EUQCXRtRnyEC", "citedby": "0"}, {"bib": {"title": "Symptom and Impact Disturbance: Findings From a Qualitative Assessment of Patients With Acute Myeloid Leukemia", "year": "2018"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:LjlpjdlvIbIC", "citedby": "0"}, {"bib": {"title": "The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome per 2017 WHO guideline compared to de novo MDS.", "year": "2018"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:a0OBvERweLwC", "citedby": "0"}, {"bib": {"title": "Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Lymphoblastic Leukemia/Lymphoma: The Mayo Clinic Experience", "year": "2018"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:dfsIfKJdRG4C", "citedby": "0"}, {"bib": {"title": "Incidence and Mortality Outcomes in Allogeneic Transplant-Associated Thrombotic Microangiopathy", "year": "2018"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:u_35RYKgDlwC", "citedby": "0"}, {"bib": {"title": "Transplant Outcomes for Patients with Secondary Acute Myeloid Leukemia (AML) Arising From Myeloproliferative Neoplasms (MPN)", "year": "2018"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:rO6llkc54NcC", "citedby": "0"}, {"bib": {"title": "Outcome of Patients with Myelodysplastic Syndrome and a Monosomal Karyotype Following Allogeneic Stem Cell Transplant: Single Institution Experience", "year": "2018"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:SeFeTyx0c_EC", "citedby": "0"}, {"bib": {"title": "Early Maintenance with Tyrosine Kinase Inhibitors Post Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Improves Survival in Ph+ Acute Lymphoblastic Leukemia (ALL \u2026", "year": "2017"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:g5m5HwL7SMYC", "citedby": "0"}, {"bib": {"title": "The Prognostic Impact of Minimal Residual Disease on Risk of Progression and Progression Free Survival in Acute Myeloid Leukemia", "year": "2017"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:M05iB0D1s5AC", "citedby": "0"}, {"bib": {"title": "Graft Failure Post Allogeneic Stem Cell Transplant: Conditioning Regimen Improves Engraftment and Survival", "year": "2017"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:ldfaerwXgEUC", "citedby": "0"}, {"bib": {"title": "HAPLOIDENTICAL TRANSPLANTATION IS SAFE AND EFFECTIVE FOR OLDER PATIENTS WITH AML/MDS", "year": "2017"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:35N4QoGY0k4C", "citedby": "0"}, {"bib": {"title": "Lung Involvement In Erdheim-Chester Disease: An Independent Prognostic Factor?", "year": "2017"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:J_g5lzvAfSwC", "citedby": "0"}, {"bib": {"title": "Real Time PCR Detects Relapse of JAK2 V617F Myelofibrosis Earlier Than Pyrosequencing after Allogeneic Transplantation", "year": "2017"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:vV6vV6tmYwMC", "citedby": "0"}, {"bib": {"title": "Pulmonary Presentation Without Concurrent Bone Involvement in Erdheim-Chester Disease: A Report of Two Cases", "year": "2016"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:maZDTaKrznsC", "citedby": "0"}, {"bib": {"title": "Bilateral Foot Gangrene", "year": "2016"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:mB3voiENLucC", "citedby": "0"}, {"bib": {"title": "MTH1 Inhibitor-Induced Cytotoxicity in Acute Myeloid Leukemia", "year": "2015"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:_Qo2XoVZTnwC", "citedby": "0"}, {"bib": {"title": "A Population-Based Study of Large Granular Lymphocyte Leukemia: Analysis of 978 Patients Using the SEER and NCDB Databases", "year": "2015"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:e5wmG9Sq2KIC", "citedby": "0"}, {"bib": {"title": "Emerging role of CEBP-\u03b1 mutations in acute myeloid leukemia", "year": "2015"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:7PzlFSSx8tAC", "citedby": "0"}, {"bib": {"title": "ADULT DISSEMINATED LANGERHANS CELL HISTIOCYTOSIS IN THE US: A POPULATION-BASED STUDY USING THE SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM", "year": "2015"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:IWHjjKOFINEC", "citedby": "0"}, {"bib": {"title": "The New ASCO/CAP HER2 Guidelines Double the Number of Breast Cancer Patients Eligible for HER2-Targeted Therapy", "year": "2014"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:L8Ckcad2t8MC", "citedby": "0"}, {"bib": {"title": "Targeting Sphingosine Kinase 1 in NK-LGL Leukemia", "year": "2012"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:W7OEmFMy1HYC", "citedby": "0"}, {"bib": {"title": "Role of sphingolipid signaling in pathogenesis of large granular lymphocyte leukemia", "year": "2008"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:qjMakFHDy7sC", "citedby": "0"}, {"bib": {"title": "Characterization of An NKp46+ NKT Subset Which Is Susceptible to Malignant Transformation in Vivo.", "year": "2008"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:eQOLeE2rZwMC", "citedby": "0"}, {"bib": {"title": "A randomized, double-blind, placebo-controlled study of buprenorphine was carried out in 20 patients after cholecystectomy. The drug was given on\" patient demand\" either im (0 \u2026", "year": "1986"}, "source": "citations", "id_citations": "oMCBfAgAAAAJ:N5tVd3kTz84C", "citedby": "0"}]}